EXCEPGEN
ExcepGen is a venture-backed, early stage biotechnology company located in San Francisco. The company is focused on solving fundamental underlying problems in drug discovery and applying those solutions to create a new generation of therapeutics.
EXCEPGEN
Social Links:
Industry:
Biopharma Biotechnology Health Care Life Science
Founded:
2018-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.excepgen.com
Total Employee:
1+
Status:
Active
Total Funding:
9.15 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Global Site Tag Amazon
Similar Organizations
ALX Oncology
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Employees Featured
Founder
Investors List
SV Angel
SV Angel investment in Seed Round - ExcepGen
Pi Campus
Pi Campus investment in Seed Round - ExcepGen
Y Combinator
Y Combinator investment in Seed Round - ExcepGen
Official Site Inspections
http://www.excepgen.com
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "ExcepGen"
ExcepGen
Major advances in capping, delivery, manufacturing, and non-natural nucleosides enabled the field to grow. These solutions, while game-changing, have all focused on engineering the โฆSee details»
ExcepGen - Crunchbase Company Profile & Funding
ExcepGen is a venture-backed, early stage biotechnology company located in San Francisco. The company is focused on solving fundamental underlying problems in drug discovery and โฆSee details»
ExcepGen Company Profile 2024: Valuation, Funding & Investors
ExcepGen General Information Description. Developer of engineering mRNA therapeutics designed to adapt to the cellular state. The company specializes in altering the way that cells โฆSee details»
ExcepGen | Team
Developing therapies that escape the binds of cellular regulation is a collaborative and multidisciplinary endeavor. We are hiring for a range of people with diverse scientific expertise. โฆSee details»
EXCEPGEN INC Company Profile | San Francisco, CA | Competitors ...
Find company research, competitor information, contact details & financial data for EXCEPGEN INC of San Francisco, CA. Get the latest business insights from Dun & Bradstreet.See details»
ExcepGen Company Profile - Office Locations, Competitors ... - Craft
ExcepGen is a company that develops a platform for drug discovery. It offers a technology that can produce active, full-length proteins from human cells with correct post-translational โฆSee details»
Excepgen, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Excepgen, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
ExcepGen - Products, Competitors, Financials, Employees, โฆ
ExcepGen is a biotechnology company specializing in the development of nucleic acid medicines within the pharmaceutical industry. The company's main offerings include gene therapies and โฆSee details»
ExcepGen - LinkedIn
ExcepGen is a venture-backed, early stage biotechnology company located in San Francisco. The company is focused on solving fundamental underlying problems in drug discovery and applying those solutions to create a new โฆSee details»
Excepgen - VentureRadar
Gennao Bio is a privately held genetic medicines company developing first-in-class targeted nucleic acid therapeutics utilizing a proprietary gene monoclonal antibody (GMAB) platform โฆSee details»
ExcepGen - Company Profile - Tracxn
ExcepGen - Developer of protein production technologies. Raised a total funding of $14M over 2 rounds from 5 investors. Founded by Barbara M in the year 2017. ExcepGen has 2835 โฆSee details»
ExcepGen - Gravity Fund
ExcepGen engineers how cells interact with mRNA vaccines and therapies. ExcepGenโs platform allows them to dampen cellular pathways that are undesirable and boost cellular pathways โฆSee details»
Excepgen - Overview, News & Similar companies | ZoomInfo.com
The post ExcepGen Raises $4M in Funding appeared first on FinSMEs. Aug 24, 2023. www.finsmes.com . ExcepGen Emerges From Stealth with New Funding for its Nucleic Acid โฆSee details»
ExcepGen emerges from stealth, targets genetic medicine revolution
Oct 4, 2023 Genetic medicine startup ExcepGen recently emerged from stealth mode with a mission to โmassively expandโ the reach of DNA and RNA-based genetic medicines by โฆSee details»
Careers - Excepgen
We are looking for individuals with a keen interest in creating technologies that improve the drug discovery and development processes. Those who can bridge the gaps between biochemistry, โฆSee details»
ExcepGen Emerges From Stealth with New Funding for its Nucleic โฆ
Aug 24, 2023 ExcepGen is an early-stage biotechnology company at the forefront of the nucleic acid therapeutics revolution. Leveraging its proprietary platform, the company aims to expand โฆSee details»
ExcepGen - Funding, Financials, Valuation & Investors - Crunchbase
ExcepGen is solving fundamental underlying problems in drug discovery to create a new generation of therapeutics. Search Crunchbase. Start Free Trial . Chrome Extension. ... How โฆSee details»
ExcepGen - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. ExcepGen . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... Monthly Visits 92. Monthly Visits Growth -47.83%. โฆSee details»
ExcepGen: Genetic Medicine Company Closes $14 Million In Total โฆ
Aug 25, 2023 ExcepGen is a genetic medicine startup that recently emerged from stealth after the successful completion of its newest funding round. The most recent $4 million round - โฆSee details»
ExcepGen emerges from Y Combinator, taking aim at better โฆ
Mar 15, 2019 ExcepGen is officially launching out of Y Combinator with technology that uses an engineered human cell line to produce full-length human proteins for use in drug discovery. Its โฆSee details»